お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:研究用抗体の世界市場
市場調査レポート
商品コード
998025

研究用抗体の世界市場

Global Markets for Research Antibodies

出版日: | 発行: BCC Research | ページ情報: 英文 266 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.72円
研究用抗体の世界市場
出版日: 2021年03月31日
発行: BCC Research
ページ情報: 英文 266 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の研究用抗体の市場規模は予測期間中6.5%のCAGRで推移し、2020年の27億米ドルから、2025年には37億米ドルの規模に成長すると予測されています。

用途別では、ウエスタンブロッティングの部門が同期間中6.3%のCAGRで推移し、2020年の6億8760万米ドルから、2025年には9億3420万米ドルに成長する見通しです。また、フローサイトメトリーの部門は8.2%CAGRで推移し、2020年の6億200万米ドルから、2025年には8億9240万米ドルに成長すると予測されています。

当レポートでは、世界の研究用抗体の市場を調査し、市場および製品の概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、製品・クローナリティ・反応性・用途・宿主・エンドユーザー・地域など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場・技術の背景

  • 市場の経緯・現状
  • 抗体とその生産
  • 現況と問題
  • 抗体技術の概要
  • 従来の抗体生成技術
  • 新たな抗体生成技術
  • 抗体の検証方法
  • 研究用抗体市場の動向
  • 購買要因の分析
  • サードパーティの品質評価システム
  • 調査助成金
  • ジャーナル引用分析
  • 抗体の生産・応用における技術的動向
  • 研究用抗体産業に関連する過去10年の取引
  • 2018-2021年のM&A

第4章 抗体の研究への応用

  • ELISA / ELISPOT
  • 直接ELISA
  • 間接ELISA
  • 競合ELISA
  • サンドイッチELISA
  • ELISPOTアッセイ
  • FluoroSpotアッセイ
  • ELISAにおける新しい技術・プラットフォーム
  • ウエスタンブロット法
  • 1次元ゲル電気泳動
  • 2次元ゲル電気泳動
  • ウエスタンブロットにおける新興技術/プラットフォーム
  • 免疫組織化学 (IHC)
  • フローサイトメトリー (セルソーティングを含む)
  • フローサイトメトリーにおける新しい技術・プラットフォーム
  • 免疫細胞化学・免疫蛍光染色
  • クロマチン免疫沈降 (ChIP)
  • 抗体の他の用途
  • 抗体アレイ

第5章 市場力学

  • 市場推進因子
  • 市場抑制因子
  • 市場機会

第6章 市場分析・予測:製品別

  • 一次抗体
  • 二次抗体

第7章 市場分析・予測:クローナリティ別

  • ポリクローナル抗体
  • モノクローナル抗体

第8章 市場分析・予測:反応性別

  • ヒト (アンチヒト)
  • マウス (アンチマウス)
  • ラット (アンチラット)

第9章 市場分析・予測:用途別

  • ウエスタンブロッティング (WB)
  • フローサイトメトリー
  • 免疫組織化学 (IHC)
  • 免疫細胞化学・免疫蛍光染色 (ICC・IFS)
  • ELISA

第10章 市場分析・予測:宿主別

  • ウサギ
  • ヤギ
  • マウス
  • ヒツジ
  • ロバ
  • その他

第11章 市場分析・予測:エンドユーザー別

  • 大学・学術機関
  • 製薬・バイオ技術企業
  • その他

第12章 市場分析・予測:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第13章 COVID-19の影響

第14章 承認済みモノクローナル抗体

第15章 バリューチェーン分析

第16章 規制シナリオ

第17章 競合情勢

  • 企業ランキング分析
  • 助成金を受けた抗体療法

第18章 企業プロファイル

  • ABCAM
  • ABSOLUTE ANTIBODY LTD.
  • AGILENT TECHNOLOGIES INC.
  • BD BIOSCIENCES
  • BECKMAN COULTER INC.
  • BIO-RAD (ABD SEROTEC)
  • BIO-TECHNE
  • CELL SIGNALING TECHNOLOGY
  • JACKSON IMMUNORESEARCH LABORATORIES INC.
  • MILLIPORESIGMA
  • ROCKLAND IMMUNOCHEMICALS INC.
  • SANTA CRUZ BIOTECHNOLOGY INC.
  • SINO BIOLOGICAL
  • THERMO FISHER SCIENTIFIC INC.
  • UNITED STATES BIOLOGICAL

第19章 付録:頭字語

図表

List of Tables

  • Summary Table : Global Market for Research Antibodies, by Application, Through 2025
  • Table 1 : Most-Cited Antibodies and Their Suppliers, 2017
  • Table 2 : Global Market for Research Antibodies, by Product, Through 2025
  • Table 3 : Examples of Clinically Important Monoclonal Antibodies
  • Table 4 : Global Market for Primary Antibodies, by Region, Through 2025
  • Table 5 : Secondary Antibody Selection
  • Table 6 : Global Market for Secondary Antibodies, by Region, Through 2025
  • Table 7 : Global Market for Research Antibodies, by Clonality, Through 2025
  • Table 8 : Global Market for Polyclonal Antibodies, by Region, Through 2025
  • Table 9 : Global Market for Monoclonal Antibodies, by Region, Through 2025
  • Table 10 : Global Market for Research Antibodies, by Major Reactivities, Through 2025
  • Table 11 : Global Market for Anti-Human Antibodies, by Region, Through 2025
  • Table 12 : Global Market for Anti-Mouse Research Antibodies, by Region, Through 2025
  • Table 13 : Rat Antibodies with Different Isotypes.
  • Table 14 : Global Market for Anti-Rat Research Antibodies, by Region, Through 2025
  • Table 15 : Global Market for Research Antibodies, by Application, Through 2025
  • Table 16 : Global Market for Western Blotting Applications, by Region, Through 2025
  • Table 17 : Global Market for Flow Cytometry Applications, by Region, Through 2025
  • Table 18 : Global Market for Immunohistochemistry (IHC) Applications, by Region, Through 2025
  • Table 19 : Global Market for Immunohistochemistry (IHC) Applications, by Region, Through 2025
  • Table 20 : Global Market for ELISA Applications, by Region, Through 2025
  • Table 21 : Global Market for Research Antibodies, by Host Species, Through 2025
  • Table 22 : Global Market for Rabbit Research Antibodies, by Region, Through 2025
  • Table 23 : Global Market for Goat Research Antibodies, by Region, Through 2025
  • Table 24 : Global Market for Mouse Research Antibodies, by Region, Through 2025
  • Table 25 : Global Market for Sheep Research Antibodies, by Region, Through 2025
  • Table 26 : Global Market for Donkey Research Antibodies, by Region, Through 2025
  • Table 27 : Global Market for Other Host Species Research Antibodies, by Region, Through 2025
  • Table 28 : Global Market for Research Antibodies, by End User, Through 2025
  • Table 29 : Global Market for Research Antibodies in Universities/Academic Institutions, by Region, Through 2025
  • Table 30 : Global Market for Research Antibodies in Pharma/Biotech Companies, by Region, Through 2025
  • Table 31 : Global Market for Research Antibodies in Other End Users, by Region, Through 2025
  • Table 32 : Global Market for Research Antibodies, by Region, Through 2025
  • Table 33 : U.S. Grants for Research, by Type of Cancer, 2017
  • Table 34 : North American Market for Research Antibodies, by Product, Through 2025
  • Table 35 : North American Market for Research Antibodies, by Clonality, Through 2025
  • Table 36 : North American Market for Research Antibodies, by Major Reactivities, Through 2025
  • Table 37 : North American Market for Research Antibodies, by Application, Through 2025
  • Table 38 : North American Market for Research Antibodies, by Host Species, Through 2025
  • Table 39 : North American Market for Research Antibodies, by End User, Through 2025
  • Table 40 : North American Market for Research Antibodies, by Country, Through 2025
  • Table 41 : Estimated New Cancer Cases in Males in Canada, 2017
  • Table 42 : Estimated New Cancer Cases in Females in Canada, 2017
  • Table 43 : European Market for Research Antibodies, by Product, Through 2025
  • Table 44 : European Market for Research Antibodies, by Clonality, Through 2025
  • Table 45 : European Market for Research Antibodies, by Major Reactivities, Through 2025
  • Table 46 : European Market for Research Antibodies, by Application, Through 2025
  • Table 47 : European Market for Research Antibodies, by Host Species, Through 2025
  • Table 48 : European Market for Research Antibodies, by End Users, Through 2025
  • Table 49 : European Market for Research Antibodies, by Country, Through 2025
  • Table 50 : Deaths Caused by Cardiovascular Disease Compared with Other Causes of Death in Germany, Percent Change 2005-2016
  • Table 51 : Diseases Causing the Greatest Number of Premature Deaths in Germany, Percentage Change from 2005-2016
  • Table 52 : Asia-Pacific Market for Research Antibodies, by Product, Through 2025
  • Table 53 : Asia-Pacific Market for Research Antibodies, by Clonality, Through 2025
  • Table 54 : Asia-Pacific Market for Research Antibodies, by Major Reactivities, Through 2025
  • Table 55 : Asia Pacific Market for Research Antibodies, by Application, Through 2025
  • Table 56 : Asia-Pacific Market for Research Antibodies, by Host Species, Through 2025
  • Table 57 : Asia-Pacific Market for Research Antibodies, by End User, Through 2025
  • Table 58 : Asia-Pacific Market for Research Antibodies, by Country, Through 2025
  • Table 59 : Incidence of All Cancers in Australia, by Sex, 2017
  • Table 60 : Rest of World Market for Research Antibodies, by Product, Through 2025
  • Table 61 : Rest of World Market for Research Antibodies, by Clonality, Through 2025
  • Table 62 : Rest of World Market for Research Antibodies, by Major Reactivities, Through 2025
  • Table 63 : Rest of World Market for Research Antibodies, by Application, Through 2025
  • Table 64 : Rest of World Market for Research Antibodies, by Host Species, Through 2025
  • Table 65 : Rest of World Market for Research Antibodies, by End User, Through 2025
  • Table 66 : Rest of World Market for Research Antibodies, by Country/Region, Through 2025
  • Table 67 : U.S. FDA-approved Monoclonal Antibodies in the Market
  • Table 68 : Global Distribution of Antibody Suppliers, by Region, 2018
  • Table 69 : Distribution of Antibody Suppliers in the U.S., by State, 2017
  • Table 70 : Antibody Therapeutics Granted First Approvals in The European Union or The United States During, 2018
  • Table 71 : Abcam: Product Portfolio
  • Table 72 : Absolute Antibody Ltd.: Product Portfolio
  • Table 73 : Agilent Technologies Inc.: Product Portfolio
  • Table 74 : BD Biosciences: Product Portfolio
  • Table 75 : Beckman Coulter Inc.: Product Portfolio
  • Table 76 : Bio-Rad: Product Portfolio
  • Table 77 : Bio-Techne: Product Portfolio
  • Table 78 : Cell Signaling Technology: Product Portfolio,by Type
  • Table 79 : Cell Signaling Technology: Products Portfolio, by Source
  • Table 80 : Jackson ImmunoResearch Laboratories: Product Portfolio
  • Table 81 : Merck KGaA: Product Portfolio
  • Table 82 : Rockland Immunochemical Inc.: Product Portfolio
  • Table 83 : Santa Cruz Biotechnology Inc.: Product Portfolio
  • Table 84 : Sino Biological: Product Portfolio
  • Table 85 : Thermo Fisher Scientific: Product Portfolio
  • Table 86 : United States Biological: Product Portfolio
  • Table 87 : United States Biological: Product Portfolio
  • Table 88 : Acronyms Used in this Report

List of Figures

  • Summary Figure : Global Market Shares for Research Antibodies, by Application, 2019
  • Figure 1 : Global Market Shares for Research Antibodies, by Product, 2019
  • Figure 2 : Global Market Shares for Research Antibodies, by Product, 2025
  • Figure 3 : Global Market for Primary Antibodies, 2018-2025
  • Figure 4 : Global Market for Primary Antibodies, by Region, 2018-2025
  • Figure 5 : Global Market for Secondary Antibodies, 2018-2025
  • Figure 6 : Global Market for Secondary Antibodies, by Region, 2018-2025
  • Figure 7 : Global Market Shares for Research Antibodies, by Clonality, 2019
  • Figure 8 : Global Market Shares for Research Antibodies, by Clonality, 2025
  • Figure 9 : Global Market for Polyclonal Antibodies, 2018-2025
  • Figure 10 : Global Market for Polyclonal Antibodies, by Region, 2018-2025
  • Figure 11 : Global Market for Monoclonal Antibodies, 2018-2025
  • Figure 12 : Global Market for Monoclonal Antibodies, by Region, 2018-2025
  • Figure 13 : Global Market Shares for Research Antibodies, by Major Reactivities, 2019
  • Figure 14 : Global Market Shares for Research Antibodies, by Major Reactivities, 2025
  • Figure 15 : Global Market for Anti-Human Research Antibodies, 2018-2025
  • Figure 16 : Global Market for Anti-Human Research Antibodies, by Region, 2018-2025
  • Figure 17 : Global Market for Anti-Mouse Research Antibodies, 2018-2025
  • Figure 18 : Global Market for Anti-Mouse Research Antibodies, by Region, 2018-2025
  • Figure 19 : Global Market for Anti-Rat Research Antibodies, 2018-2025
  • Figure 20 : Global Market for Anti-Rat Research Antibodies, by Region, 2018-2025
  • Figure 21 : Global Market Shares for Research Antibodies, by Application, 2019
  • Figure 22 : Global Market Shares for Research Antibodies, by Application, 2025
  • Figure 23 : Global Market for Western Blot Applications, 2018-2025
  • Figure 24 : Global Market for Western Blotting Applications, by Region, 2018-2025
  • Figure 25 : Global Market for Flow Cytometry Applications, 2018-2025
  • Figure 26 : Global Market for Flow Cytometry Applications, by Region, 2018-2025
  • Figure 27 : Estimated New Cases of Leukemia, Lymphoma and Myeloma, 2020
  • Figure 28 : Global Market for Immunohistochemistry (IHC) Applications, 2018-2025
  • Figure 29 : Global Market for Immunohistochemistry (IHC) Applications, by Region, 2018-2025
  • Figure 30 : Global Market for Immunohistochemistry (IHC) Applications, 2018-2025
  • Figure 31 : Global Market for Immunohistochemistry (IHC) Applications, by Region, 2018-2025
  • Figure 32 : Global Market for ELISA Applications, 2018-2025
  • Figure 33 : Global Market for ELISA Application Segment, by Region, 2018-2025
  • Figure 34 : Global Market Shares for Research Antibodies, by Host Species, 2019
  • Figure 35 : Global Market Shares for Research Antibodies, by Host Species, 2025
  • Figure 36 : Number of Rabbits used in Research, Testing and Teaching in the U.S., 2012-2018
  • Figure 37 : Global Market for Rabbit Research Antibodies, 2018-2025
  • Figure 38 : Global Market for Rabbit Research Antibodies, by Region, 2018-2025
  • Figure 39 : Global Market for Goat Research Antibodies, 2018-2025
  • Figure 40 : Global Market for Goat Research Antibodies, by Region, 2018-2025
  • Figure 41 : Global Market for Mouse Research Antibodies, 2018-2025
  • Figure 42 : Global Market for Mouse Research Antibodies, by Region, 2018-2025
  • Figure 43 : Global Market for Sheep Research Antibodies, 2018-2025
  • Figure 44 : Global Market for Sheep Research Antibodies, by Region, 2018-2025
  • Figure 45 : Global Market for Donkey Research Antibodies, 2018-2025
  • Figure 46 : Global Market for Donkey Research Antibodies, by Region, 2018-2025
  • Figure 47 : Global Market for Other Host Species Research Antibodies, 2018-2025
  • Figure 48 : Global Market for Other Host Species Research Antibodies, by Region, 2018-2025
  • Figure 49 : Global Market Shares for Research Antibodies, by End User, 2019
  • Figure 50 : Global Market Shares for Research Antibodies, by End User, 2025
  • Figure 51 : Global Incidence of Patients with Chronic Diseases, 2005-2030
  • Figure 52 : Global Market for Research Antibodies in Universities/Academic Institutions, 2018-2025
  • Figure 53 : Global Market for Research Antibodies in Universities/Academic Institutions, by Region, 2018-2025
  • Figure 54 : Global Market for Research Antibodies in Pharma/Biotech Companies, 2018-2025
  • Figure 55 : Global Market for Research Antibodies in Pharma/Biotech Companies, by Region, 2018-2025
  • Figure 56 : Global Market for Research Antibodies in Other End Users, 2018-2025
  • Figure 57 : Global Market for Research Antibodies in Other End Users, by Region, 2018-2025
  • Figure 58 : Global Market Shares for Research Antibodies, by Region, 2019
  • Figure 59 : Global Market Shares for Research Antibodies, by Region, 2025
  • Figure 60 : North American Market Shares for Research Antibodies, by Product, 2019
  • Figure 61 : North American Market Shares for Research Antibodies, by Clonality, 2019
  • Figure 62 : North American Market Shares for Research Antibodies Market, by Major Reactivities, 2019
  • Figure 63 : North American Market Shares for Research Antibodies, by Application, 2019
  • Figure 64 : North American Market Shares for Research Antibodies, by Host Species, 2019
  • Figure 65 : North American Market Shares for Research Antibodies, by End User, 2019
  • Figure 66 : North American Market Shares for Research Antibodies, by Country, 2019
  • Figure 67 : U.S. Market for Research Antibodies, 2018-2025
  • Figure 68 : Canadian Market for Research Antibodies, 2018-2025
  • Figure 69 : Mexican Market for Research Antibodies, 2018-2025
  • Figure 70 : European Market Shares for Research Antibodies, by Product, 2019
  • Figure 71 : European Market Shares for Research Antibodies, by Clonality, 2019
  • Figure 72 : European Market Shares for Research Antibodies, by Major Reactivities, 2019
  • Figure 73 : European Market Shares for Research Antibodies, by Application, 2019
  • Figure 74 : European Market Shares for Research Antibodies, by Host Species, 2019
  • Figure 75 : European Market Shares for Research Antibodies, by End User, 2019
  • Figure 76 : European Market Shares for Research Antibodies, by Country, 2019
  • Figure 77 : German Market for Research Antibodies, 2018-2025
  • Figure 78 : French Market for Research Antibodies, 2018-2025
  • Figure 79 : Health Spending and Financing in France, 2005-2018
  • Figure 80 : Market Demand for Medical Equipment in France, 2015-2017
  • Figure 81 : U.K. Market for Research Antibodies, 2018-2025
  • Figure 82 : Italian Market for Research Antibodies, 2018-2025
  • Figure 83 : Spanish Market for Research Antibodies, 2018-2025
  • Figure 84 : Rest of European Market for Research Antibodies, 2018-2025
  • Figure 85 : Asia-Pacific Market Shares for Research Antibodies, by Product, 2019
  • Figure 86 : Asia-Pacific Market Shares for Research Antibodies, by Clonality, 2019
  • Figure 87 : Asia-Pacific Market Shares for Research Antibodies, by Major Reactivities, 2019
  • Figure 88 : Asia-Pacific Market Shares for Research Antibodies, by Application, 2019
  • Figure 89 : Asia-Pacific Market Shares for Research Antibodies, by Host Species, 2019
  • Figure 90 : Asia-Pacific Market Shares for Research Antibodies, by End User, 2019
  • Figure 91 : Asia-Pacific Market Shares for Research Antibodies, by Country, 2019
  • Figure 92 : Japanese Market for Research Antibodies, 2018-2025
  • Figure 93 : Chinese Market for Research Antibodies, 2018-2025
  • Figure 94 : Indian Market for Research Antibodies, 2018-2025
  • Figure 95 : Australian and New Zealand Market for Research Antibodies, 2018-2025
  • Figure 96 : Rest of Asia-Pacific Market for Research Antibodies, 2018-2025
  • Figure 97 : Rest of the World Market Shares for Research Antibodies, by Product, 2019
  • Figure 98 : Rest of the World Market Shares for Research Antibodies, by Clonality, 2019
  • Figure 99 : Rest of the World Market Shares for Research Antibodies, by Major Reactivities, 2019
  • Figure 100 : Rest of the World Market Shares for Research Antibodies, by Application, 2019
  • Figure 101 : Rest of the World Market Shares for Research Antibodies, by Host Species, 2019
  • Figure 102 : Rest of the World Market Shares for Research Antibodies Major Reactivities, by End User, 2019
  • Figure 103 : Rest of the World Market Shares for Research Antibodies, by Country/Region, 2019
  • Figure 104 : Brazilian Market for Research Antibodies, 2018-2025
  • Figure 105 : GCC Countries Market for Research Antibodies, 2018-2025
  • Figure 106 : Rest of World Countries Market for Research Antibodies, 2018-2025
  • Figure 107 : Impact of COVID-19 on the Pharmaceutical/Biotech Industry
  • Figure 108 : Value Chain Analysis
  • Figure 109 : Global Market Ranking of Research Antibodies, by Manufacturer, 2019
  • Figure 110 : Abcam: Annual Revenue, 2018-2020
  • Figure 111 : Agilent Technologies Inc.: Annual Revenue, 2016-2020
  • Figure 112 : Agilent Technologies Inc.: Revenue Shares, by Region, 2019
  • Figure 113 : Agilent Technologies Inc.: Revenue Shares, by Business Segments, 2020
  • Figure 114 : BD Biosciences: Annual Revenue, 2016-2019
  • Figure 115 : BD Biosciences: Revenue Shares, by Region, 2019
  • Figure 116 : BD Biosciences: Revenue Shares, by Business Segments, 2020
  • Figure 117 : Bio-Rad: Annual Revenue, 2016-2019
  • Figure 118 : Bio-Rad: Revenue Shares, by Region, 2019
  • Figure 119 : Bio-Rad: Revenue Shares, by Business Unit, 2019
  • Figure 120 : Bio-Techne: Annual Revenue, 2016-2019
  • Figure 121 : Bio-Techne: Revenue Shares, by Region, 2019
  • Figure 122 : Bio-Techne: Revenue Shares, by Business Segment, 2019
  • Figure 123 : Merck KGaA: Annual Revenue, 2016-2019
  • Figure 124 : Merck KGaA: Revenue Shares, by Region, 2019
  • Figure 125 : Merck KGaA: Revenue Shares, by Investment, 2019
  • Figure 126 : Thermo Fisher Scientific: Annual Revenue, 2016-2019
  • Figure 127 : Thermo Fisher Scientific: Revenue Shares, by Region, 2019
  • Figure 128 : Thermo Fisher Scientific: Revenue Shares, by Business Segments, 2019
目次
Product Code: BIO141C

Highlights:

The global market for research antibodies should grow from $2.7 billion in 2020 to $3.7 billion by 2025 with a compound annual growth rate (CAGR) of 6.5% for the period of 2020-2025.

Western blotting market for research antibodies should grow $687.6 million in 2020 to $934.2 million by 2025 with a compound annual growth rate (CAGR) of 6.3% for the period of 2020-2025.

Flow cytometry market for research antibodies should grow $602.0 million in 2020 to $892.4 million by 2025 with a compound annual growth rate (CAGR) of 8.2% for the period of 2020-2025.

Report Scope:

This study focuses on the market side of research antibodies rather than the technical side. Different market segments for this specific market are covered. For example, application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF), and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/ biotech companies and other types of customers such as governmental research labs and CROs; geography-based market segments include North America, Europe, Asia-Pacific, and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.

In this report the market for research antibodies is segmented based on product type, major reactivities, applications, and geography. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA inhibitors, and other inhibitors (RNA, Mycolic Acid, Folic Acid). Based on major reactivities, the market is segmented into oral and topical. The market is also presented based on application type, which is further segmented into human and veterinary.

By geography, the market has been segmented into the North America, Europe, Asia-Pacific, and Rest of the World (South America, and Middle East and Africa) regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries, and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2025.

Report Includes:

  • 64 data tables and 25 additional tables
  • An overview of the global market for research antibodies
  • Estimation of the market size and analyses of global market trends, with data from 2018, 2019, 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Discussion on the factors affecting the companies' market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
  • Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
  • Market share analysis of research antibodies based on product, clonality, application, end-user and region and evaluation of current market trends, market size and forecast
  • Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
  • Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry's growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
  • Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players of the industry, including Merck KGaA, Thermo Fisher Scientific, United States Biological, Beckman Coulter Inc., Agilent Technologies Inc. and Cell Signaling Technology

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Introduction
  • History and Current State
  • Background of the Antibody and Its Production
  • Current Status and Issues
  • Overview of Antibody Technology
  • Traditional Antibody Generation Technologies
  • Emerging Antibody Generation Technologies
  • Antibody Validation Methods
  • Trends in the Market for Research Antibodies
  • Purchasing Factors Analysis
  • Third-Party Quality Evaluation Systems
  • Research Grants
  • Journal Citations Analysis
  • Technological Trends in Antibody Production and Application
  • Deals within Last Decade Related to the Research Antibody Industry
  • WuXi App Tec Acquires Abgent
  • Abcam Acquires Epitomics
  • Agilent Acquires Dako
  • Affymetrix Acquires eBioscience
  • Bio-Rad Acquires AbD Serotec
  • Active Motif Acquires SwitchGear Genomics Inc.
  • Thermo Fisher Pierce Antibodies Merges with Life Technologies Corp.
  • Fluidigm Acquires DVS Sciences
  • Bio-Techne (R&D Systems) Acquires Novus Biologicals
  • Bio-Techne (R&D Systems) Acquires ProteinSimple
  • BioLegend Acquires Covance Antibody Services
  • German Merck Acquires Sigma
  • Abcam Acquires Firefly Bioworks
  • OriGene Technologies Acquires Acris Antibodies GmbH
  • Abcam Acquires AxioMx
  • Valiant Co. Ltd. Acquires MP Biomedicals
  • Thermo Fisher Scientific Acquires Affymetrix
  • Aviva Systems Biology Acquires GenWay Biotech
  • M&A Deals in 2018-2021
  • LSBio Acquires Absolute Antibody and Kerafast
  • Eurobio Scientific Acquires Dendritics
  • ImmunoPrecise Acquires Modiquest Research BV
  • LSBio Acquisitions in 2020 and 2019
  • Thermo Fisher Acquires Mesa Biotech
  • Sanofi to Acquire Kymab

Chapter 4 Research Applications of Antibodies

  • Introduction
  • ELISA/ELISPOT
  • Direct ELISA
  • Indirect ELISA
  • Competitive ELISA
  • Sandwich ELISA
  • ELISPOT Assays
  • FluoroSpot Assays
  • Emerging Technologies or Platforms in ELISA
  • Western Blot
  • 1-D Gel Electrophoresis
  • 2-D Gel Electrophoresis
  • Emerging Technologies/Platforms in Western Blot
  • Immunohistochemistry (IHC)
  • Flow Cytometry (Including Cell Sorting)
  • Emerging Technologies or Platforms in Flow Cytometry
  • Immunocytochemistry/Immunofluorescent Staining
  • Chromatin Immunoprecipitation (ChIP)
  • Other Applications of Antibodies
  • Antibody Arrays

Chapter 5 Market Dynamics

  • Market Drivers
  • New Discoveries in Biological Sciences
  • Rapid Technological Developments in the IVD Industry
  • New Antibody Technologies and Antibody Types
  • Antibody-Based Drug Discovery and Development
  • Developed and Increasing Research Areas
  • Increased Government Funding in Emerging Markets
  • Need for Further Human Genomic and Proteomic Research
  • Need for Quality Antibodies in the Current Research Community
  • Need for Antibody Custom Services
  • New Application-Focused Technology Platforms
  • Market Restraints
  • Limited Research Funding
  • Low Validation Technologies
  • Decline in Suppliers
  • Decrease in Market Acceptance or Brand Trust
  • Market Opportunities
  • Market Expansion into Emerging Countries
  • Development of Novel Research Antibodies

Chapter 6 Market Breakdown by Product

  • Global Market for Research Antibodies by Product
  • Primary Antibodies
  • Secondary Antibodies

Chapter 7 Market Breakdown by Clonality

  • Global Market for Research Antibodies by Clonality
  • Polyclonal Antibodies
  • Monoclonal Antibodies

Chapter 8 Market Breakdown by Major Reactivities

  • Global Market for Research Antibodies by Major Reactivities
  • Human (Anti-Human)
  • Mouse (Anti-Mouse)
  • Rat (Anti-Rat)

Chapter 9 Market Breakdown by Application

  • Global Market for Research Antibodies by Application
  • Western Blotting (WB)
  • Flow Cytometry
  • Immunohistochemistry (IHC)
  • Immunocytochemistry/Immunofluorescent Staining (ICC/IFS)
  • ELISA

Chapter 10 Market Breakdown by Host Species

  • Global Market for Research Antibodies by Host Species
  • Rabbit Host Species
  • Goat Host Species
  • Mouse-Host Species
  • Sheep Host Species
  • Donkey Host Species
  • Other Host Species

Chapter 11 Market Breakdown by End User

  • Global Market for Research Antibodies by End User
  • Universities/Academic Institutions
  • Pharma/Biotech Companies
  • Other End Users

Chapter 12 Market Breakdown by Region

  • Global Market for Research Antibodies by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Chapter 13 Impact of COVID-19 on the Pharmaceutical/Biotechnology Industry

  • Short-term Impacts
  • Change in Demand
  • Shift of Communication and Promotions to Remote Interactions
  • Research and Development Changes
  • Long-term Impact
  • Delayed Approvals for Non-COVID-related Pharmaceutical/Biotech Products
  • Self-sufficiency in Pharma/Biotech Industry
  • Pharmaceutical Industry Growth Slow-Down
  • Changes in Consumption Trends in Health-related Products

Chapter 14 Approved Monoclonal Antibodies, 1986-2019

Chapter 15 Value Chain Analysis

  • Introduction
  • China Is Becoming a Center of Microbial Threats

Chapter 16 Regulatory Scenario

  • FDA and International Regulation
  • Recent Regulatory Reforms

Chapter 17 Competitive Landscape

  • Global Company Market Ranking Analysis
  • Antibody Therapeutics Granted in 2018

Chapter 18 Company Profiles

  • ABCAM
  • ABSOLUTE ANTIBODY LTD.
  • AGILENT TECHNOLOGIES INC.
  • BD BIOSCIENCES
  • BECKMAN COULTER INC.
  • BIO-RAD (ABD SEROTEC)
  • BIO-TECHNE
  • CELL SIGNALING TECHNOLOGY
  • JACKSON IMMUNORESEARCH LABORATORIES INC.
  • MILLIPORESIGMA
  • ROCKLAND IMMUNOCHEMICALS INC.
  • SANTA CRUZ BIOTECHNOLOGY INC.
  • SINO BIOLOGICAL
  • THERMO FISHER SCIENTIFIC INC.
  • UNITED STATES BIOLOGICAL

Chapter 19 Appendix: Acronyms

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.